Although it is not currently known whether these abnormalities are linked to comorbidities, such as alcoholism, inflammatory, and autoimmune disorders, or metabolic disorders [201–203], these findings support the intriguing possibility that tPA abnormalities may contribute to a disruption of glutamatergic transmission in schizophrenia. This evidence concerns the gene PLAT and schizophrenia.